Laserfiche WebLink
individuals should be followed for changes in blood variables and the delayed appearance <br /> of pulmonary edema and chemical pneumonitis. Such patients should be followed for several <br /> days or weeks for delayed effects, including bone marrow toxicity, hepatic and renal <br /> impairment. Individuals with chronic pulmonary disease will be more seriously impaired, <br /> and recovery from inhalation exposure may be complicated. In case of skin injection, <br /> prompt debridement of the wound is necessary to minimize necrosis and tissue loss. <br /> . .� <br /> PERSONAL PQ' 'EC'[It)N':INFQRMN' <br /> SKIN PROTECTION: <br /> Wear impervious gloves and protective clothing to prevent skin contact. <br /> RESPIRATORY PROTECTION: <br /> Use NIOSH or MSHA approved equipment when airborne exposure limits are exceeded. <br /> NIOSH/MSHA approved breathing equipment must be available for non-routine and emergency <br /> use. Ventilation may be used to control or reduce airborne concentrations. <br /> 311 <br /> NEW <br /> PHlCA PRC?PRT ��.. <br /> :4'i.11111nlllwi`�s�.3fai-y <br />